GGlencore Read More Why Glencore chose Guinea’s bauxite over Queensland’s Aurukun2026-09-18 Is Queensland mining that much on the nose? We’ve heard that Parliament House has been all abuzz this…
RRoche Read More Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD2026-04-22 Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)MOGAD is…